MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517098124 A) filed by Arnay Sciences, Llc, Shrewsbury, U.S.A., on Oct. 11, for 'cyclic antisense therapeutics.'
Inventor(s) include Agrawal, Sudhir; and Vathipadiekal, Vinod.
The application for the patent was published on Nov. 21, under issue no. 47/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides oligonucleotides referred to as cyclic structured oligonucleotides ("CSOs") comprising a functional domain, a cyclizing domain, and a linker segment as described herein, compositions comprising same, and methods of using same. This design of cyclic oligonucleotides maintains a cyclic form until it is in the presence of and hybridizes with a targeted RNA."
The patent application was internationally filed on Mar. 21, 2024, under International application No.PCT/US2024/020914.
Disclaimer: Curated by HT Syndication.
